|
|
Previous Article | Table of Contents | Next Article 
Role of c-mpl in Early Hematopoiesis
Gregg P. Solar,
William G. Kerr,
Francis C. Zeigler,
Darren Hess,
Christopher Donahue,
Frederic J. de Sauvage, and
Dan L. Eaton
From the Departments of Cardiovascular Research, Molecular Oncology
and Flow Cytometry, Genentech Inc, South San Francisco, CA; and the
Department of Molecular and Cellular Engineering, Institute for Human
Gene Therapy, University of Pennsylvania, Philadelphia.
Recently, several lines of evidence have indicated an expanded role
for thrombopoietin (TPO) and its receptor, c-mpl, in
hematopoiesis. In addition to being the primary physiological regulator
of platelet production, it is now apparent that TPO also acts during
early hematopoiesis. To futher define the role of TPO in early
hematopoiesis we have identified discrete murine and human stem cell
populations with respect to c-mpl expression and evaluated their
potential for hematopoietic engraftment. Fluorescence-activated cell
sorter analysis of enriched stem cell populations showed the presence of c-mpl expressing subpopulations. Approximately 50% of the murine fetal liver stem cell-enriched population,
AA4+Sca+c-kit+,
expressed c-mpl. Analysis of the murine marrow stem cell population LinloSca+c-kit+ showed that
70% of this population expressed c-mpl. Expression of c-mpl was also
detected within the human bone marrow
CD34+CD38 stem cell progenitor pool and
approximately 70% of that population expressed c-mpl. To rigorously
evaluate the role of TPO/c-mpl in early hematopoiesis we compared the
repopulation capacity of murine stem cell populations with respect to
c-mpl expression in a competitive repopulation assay. When
comparing the fetal liver progenitor populations,
AA4+Sca+c-kit+c-mpl+
and
AA4+Sca+c-kit+c-mpl ,
we found that stem cell activity segregates with c-mpl expression. This
result is complemented by the observation that the
LinloSca+ population of c-mpl
gene-deficient mice was sevenfold less potent than
LinloSca+ cells from wild-type mice in
repopulating activity. The engraftment potential of the human
CD34+CD38 c-mpl+ population
was evaluated in a severe combined immunodeficient-human bone model. In comparison to the CD34+
CD38 c-mpl population, the
CD34+CD38 c-mpl+ cells showed
significantly better engraftment. These results demonstrate a
physiological role for TPO and its receptor, c-mpl, in regulating early
hematopoiesis.
Blood, Vol. 92 No. 1 (July 1), 1998:
pp. 4-10
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. O. Lee, J. M. Davidson, and R. J. Duronio
Endoreplication: polyploidy with purpose
Genes & Dev.,
November 1, 2009;
23(21):
2461 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Constantinescu
Mpl and thrombocytosis: levels matter
Blood,
February 19, 2009;
113(8):
1617 - 1618.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Lannutti, A. Epp, J. Roy, J. Chen, and N. C. Josephson
Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis
Blood,
February 19, 2009;
113(8):
1778 - 1785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tiedt, J. Coers, S. Ziegler, A. Wiestner, H. Hao-Shen, C. Bornmann, J. Schenkel, S. Karakhanova, F. J. de Sauvage, C. W. Jackson, et al.
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes
Blood,
February 19, 2009;
113(8):
1768 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Satoh, I. Matsumura, H. Tanaka, S. Ezoe, K. Fukushima, M. Tokunaga, M. Yasumi, H. Shibayama, M. Mizuki, T. Era, et al.
AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells
J. Biol. Chem.,
October 31, 2008;
283(44):
30045 - 30056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yokomizo and E. Dzierzak
Fine-tuning of hematopoietic stem cell homeostasis: novel role for ubiquitin ligase
Genes & Dev.,
April 15, 2008;
22(8):
960 - 963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abdel-Azim, Y. Zhu, R. Hollis, X. Wang, S. Ge, Q.-L. Hao, G. Smbatyan, D. B. Kohn, M. Rosol, and G. M. Crooks
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl
Blood,
April 15, 2008;
111(8):
4064 - 4074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Thoren, K. Liuba, D. Bryder, J. M. Nygren, C. T. Jensen, H. Qian, J. Antonchuk, and S.-E. W. Jacobsen
Kit Regulates Maintenance of Quiescent Hematopoietic Stem Cells
J. Immunol.,
February 15, 2008;
180(4):
2045 - 2053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Historical review: megakaryopoiesis and thrombopoiesis
Blood,
February 1, 2008;
111(3):
981 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood,
January 15, 2008;
111(2):
492 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chaligne, C. James, C. Tonetti, R. Besancenot, J. P. Le Couedic, F. Fava, F. Mazurier, I. Godin, K. Maloum, F. Larbret, et al.
Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis
Blood,
November 15, 2007;
110(10):
3735 - 3743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Petit-Cocault, C. Volle-Challier, M. Fleury, B. Peault, and M. Souyri
Dual role of Mpl receptor during the establishment of definitive hematopoiesis
Development,
August 15, 2007;
134(16):
3031 - 3040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Abkowitz and J. Chen
Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones
Blood,
June 15, 2007;
109(12):
5186 - 5190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tong, R. Sulahian, A. W. Gross, N. Hendon, H. F. Lodish, and L. J.-s. Huang
The Membrane-proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by JAK2-dependent and -independent Mechanisms
J. Biol. Chem.,
December 15, 2006;
281(50):
38930 - 38940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Buza-Vidas, J. Antonchuk, H. Qian, R. Mansson, S. Luc, S. Zandi, K. Anderson, S. Takaki, J. M. Nygren, C. T. Jensen, et al.
Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK
Genes & Dev.,
August 1, 2006;
20(15):
2018 - 2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Desponts, A. L. Hazen, K. H. T. Paraiso, and W. G. Kerr
SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation
Blood,
June 1, 2006;
107(11):
4338 - 4345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Lineage-specific hematopoietic growth factors.
N. Engl. J. Med.,
May 11, 2006;
354(19):
2034 - 2045.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Hamelin, C. Letourneux, P.-H. Romeo, F. Porteu, and M. Gaudry
Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation
Blood,
April 15, 2006;
107(8):
3106 - 3113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Staerk, C. Lacout, T. Sato, S. O. Smith, W. Vainchenker, and S. N. Constantinescu
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor
Blood,
March 1, 2006;
107(5):
1864 - 1871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Verhoeyen, M. Wiznerowicz, D. Olivier, B. Izac, D. Trono, A. Dubart-Kupperschmitt, and F.-L. Cosset
Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells
Blood,
November 15, 2005;
106(10):
3386 - 3395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Royer, J. Staerk, M. Costuleanu, P. J. Courtoy, and S. N. Constantinescu
Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability
J. Biol. Chem.,
July 22, 2005;
280(29):
27251 - 27261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Zhu, E. Gerbino, D. M. Beaupre, P. A. Mackley, C. Muro-Cacho, C. Beam, A. D. Hamilton, M. G. Lichtenheld, W. G. Kerr, W. Dalton, et al.
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells
Blood,
June 15, 2005;
105(12):
4759 - 4766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Zhang and H. F. Lodish
Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion
Blood,
June 1, 2005;
105(11):
4314 - 4320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, D. Bryder, J. Adolfsson, J. Nygren, R. Mansson, M. Sigvardsson, and S. E. W. Jacobsen
Identification of Lin-Sca1+kit+CD34+Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients
Blood,
April 1, 2005;
105(7):
2717 - 2723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Koka, C. M. R. Kitchen, and S. T. Reddy
Targeting c-Mpl for Revival of Human Immunodeficiency Virus Type 1-Induced Hematopoietic Inhibition When CD34+ Progenitor Cells Are Re-Engrafted into a Fresh Stromal Microenvironment In Vivo
J. Virol.,
October 15, 2004;
78(20):
11385 - 11392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kirito, N. Fox, and K. Kaushansky
Thrombopoietin Induces HOXA9 Nuclear Transport in Immature Hematopoietic Cells: Potential Mechanism by Which the Hormone Favorably Affects Hematopoietic Stem Cells
Mol. Cell. Biol.,
August 1, 2004;
24(15):
6751 - 6762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Bradley, C. Couldrey, and K. D. Bunting
Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness
Blood,
April 15, 2004;
103(8):
2965 - 2972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Feese, T. Tamada, Y. Kato, Y. Maeda, M. Hirose, Y. Matsukura, H. Shigematsu, T. Muto, A. Matsumoto, H. Watarai, et al.
Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment
PNAS,
February 17, 2004;
101(7):
1816 - 1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Helgason, J. Antonchuk, C. Bodner, and R. K. Humphries
Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice
Blood,
November 15, 2003;
102(10):
3541 - 3547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kirito, N. Fox, and K. Kaushansky
Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells
Blood,
November 1, 2003;
102(9):
3172 - 3178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sitnicka, N. Buza-Vidas, S. Larsson, J. M. Nygren, K. Liuba, and S. E. W. Jacobsen
Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells
Blood,
August 1, 2003;
102(3):
881 - 886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, L. Yang, D. Bryder, I. Aastrand-Grundstrom, K. Leandersson, and S. E. W. Jacobsen
Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
Blood,
July 1, 2003;
102(1):
118 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood,
December 15, 2002;
100(13):
4272 - 4290.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Banu, S. Avraham, and H. K. Avraham
P-Selectin, and Not E-Selectin, Negatively Regulates Murine Megakaryocytopoiesis
J. Immunol.,
October 15, 2002;
169(8):
4579 - 4585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Linden and K. Kaushansky
The Glycan Domain of Thrombopoietin (TPO) Acts in trans to Enhance Secretion of the Hormone and Other Cytokines
J. Biol. Chem.,
September 13, 2002;
277(38):
35240 - 35247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Challier, L. Cocault, R. Berthier, N. Binart, I. Dusanter-Fourt, G. Uzan, and M. Souyri
The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells
Blood,
August 28, 2002;
100(6):
2063 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Haznedaroglu, H. Goker, M. Turgut, Y. Buyukasik, and M. Benekli
Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2002;
8(3):
193 - 212.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky, N. Fox, N. L. Lin, and W. C. Liles
Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice
Blood,
May 15, 2002;
99(10):
3573 - 3578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Henckaerts, H. Geiger, J. C. Langer, P. Rebollo, G. Van Zant, and H.-W. Snoeck
Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines
Blood,
May 13, 2002;
99(11):
3947 - 3954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Basser, E. O'Flaherty, M. Green, M. Edmonds, J. Nichol, D. M. Menchaca, B. Cohen, and C. G. Begley
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
Blood,
April 1, 2002;
99(7):
2599 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Meunier, D. Bordereaux, F. Porteu, S. Gisselbrecht, S. Chretien, and G. Courtois
Cloning and Characterization of a Family of Proteins Associated with Mpl
J. Biol. Chem.,
March 8, 2002;
277(11):
9139 - 9147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-D. Filippi, F. Porteu, F. L. Pesteur, V. Schiavon, G. A. Millot, W. Vainchenker, F. J. de Sauvage, A. Dubart Kupperschmitt, and F. Sainteny
Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro
Blood,
February 15, 2002;
99(4):
1174 - 1182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Bunting, H. L. Bradley, T. S. Hawley, R. Moriggl, B. P. Sorrentino, and J. N. Ihle
Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5
Blood,
January 15, 2002;
99(2):
479 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Millot, W. Vainchenker, D. Dumenil, and F. Svinarchuk
Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells
J. Cell Sci.,
January 6, 2002;
115(11):
2329 - 2337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Snow, N. Abraham, M. C. Ma, N. W. Abbey, B. Herndier, and M. A. Goldsmith
STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells
Blood,
January 1, 2002;
99(1):
95 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. I. Pestina, J. L. Cleveland, C. Yang, G. P. Zambetti, and C. W. Jackson
Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis
Blood,
October 1, 2001;
98(7):
2084 - 2090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Levin, L. Cocault, C. Demerens, C. Challier, M. Pauchard, J. Caen, and M. Souyri
Thrombocytopenic c-mpl{-}/{-} mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response
Blood,
August 15, 2001;
98(4):
1019 - 1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zeng, M. Masuko, L. Jin, T. Neff, K. G. Otto, and C. A. Blau
Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells
Blood,
July 15, 2001;
98(2):
328 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Majka, A. Janowska-Wieczorek, J. Ratajczak, K. Ehrenman, Z. Pietrzkowski, M. A. Kowalska, A. M. Gewirtz, S. G. Emerson, and M. Z. Ratajczak
Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
Blood,
May 15, 2001;
97(10):
3075 - 3085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Car and V. M. Eng
Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice
Vet. Pathol.,
January 1, 2001;
38(1):
20 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ballmaier, M. Germeshausen, H. Schulze, K. Cherkaoui, S. Lang, A. Gaudig, S. Krukemeier, M. Eilers, G. Strau{beta}, and K. Welte
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
Blood,
January 1, 2001;
97(1):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ema, H. Takano, K. Sudo, and H. Nakauchi
In Vitro Self-Renewal Division of Hematopoietic Stem Cells
J. Exp. Med.,
November 6, 2000;
192(9):
1281 - 1288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Luoh, E. Stefanich, G. Solar, H. Steinmetz, T. Lipari, T. I. Pestina, C. W. Jackson, and F. J. de Sauvage
Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo
Mol. Cell. Biol.,
January 15, 2000;
20(2):
507 - 515.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. W. Greenberg, W. G. Kerr, and D. A. Hammer
Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development
Blood,
January 15, 2000;
95(2):
478 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gainsford, H. Nandurkar, D. Metcalf, L. Robb, C. G. Begley, and W. S. Alexander
The residual megakaryocyte and platelet production in c-Mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor
Blood,
January 15, 2000;
95(2):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tordjman, N. Ortega, L. Coulombel, J. Plouet, P.-H. Romeo, and V. Lemarchandel
Neuropilin-1 Is Expressed on Bone Marrow Stromal Cells: A Novel Interaction With Hematopoietic Cells?
Blood,
October 1, 1999;
94(7):
2301 - 2309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fichelson, J.-M. Freyssinier, F. Picard, M. Fontenay-Roupie, M. Guesnu, M. Cherai, S. Gisselbrecht, and F. Porteu
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in Primitive Cord Blood Hematopoietic Progenitors
Blood,
September 1, 1999;
94(5):
1601 - 1613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yagi, K. A. Ritchie, E. Sitnicka, C. Storey, G. J. Roth, and S. Bartelmez
Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
PNAS,
July 6, 1999;
96(14):
8126 - 8131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stoffel, S. Ziegler, N. Ghilardi, B. Ledermann, F. J. de Sauvage, and R. C. Skoda
Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
PNAS,
January 19, 1999;
96(2):
698 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Thrombopoietin and the Hematopoietic Stem Cell
Blood,
July 1, 1998;
92(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyakawa, P. Rojnuckarin, T. Habib, and K. Kaushansky
Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes
J. Biol. Chem.,
January 19, 2001;
276(4):
2494 - 2502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyakawa, J. G. Drachman, B. Gallis, A. Kaushansky, and K. Kaushansky
A Structure-Function Analysis of Serine/Threonine Phosphorylation of the Thrombopoietin Receptor, c-Mpl
J. Biol. Chem.,
October 6, 2000;
275(41):
32214 - 32219.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|